[HTML][HTML] Acute cellular and antibody-mediated rejection of the pancreas allograft: incidence, risk factors and outcomes
SV Niederhaus, GE Leverson, DF Lorentzen… - American Journal of …, 2013 - Elsevier
Antibody-mediated rejection (AMR) after pancreas transplantation is a recently identified
entity. We describe the incidence of, risk factors for, and outcomes after AMR, and the
correlation of C4d immunostaining and donor-specific antibody (DSA) in the diagnosis of
AMR. We retrospectively analyzed 162 pancreas transplants in 159 patients who underwent
94 pancreas allograft biopsies between 2006 and 2009. Univariate and multivariate
analyses were performed to evaluate risk factors for pancreas graft AMR. One-year rejection …
entity. We describe the incidence of, risk factors for, and outcomes after AMR, and the
correlation of C4d immunostaining and donor-specific antibody (DSA) in the diagnosis of
AMR. We retrospectively analyzed 162 pancreas transplants in 159 patients who underwent
94 pancreas allograft biopsies between 2006 and 2009. Univariate and multivariate
analyses were performed to evaluate risk factors for pancreas graft AMR. One-year rejection …